ChEMBL | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

709 results for “ChEMBL”

Trials

View all 572 →

Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study

80 participants · First posted Mar 6, 2026

Ashwagandha for Cognitive Dysfunction

80 participants · First posted Sep 17, 2019

Treatment of Post-Chemo Cognitive Impairment w/Transcranial Magnetic Stimulation (Chemobrain TMS)

1 participants · First posted Mar 4, 2020

Drugs

View all 55 →

Investigational

rhMBL

CHMFL-074

ANXV-chemo

Organizations

View all 17 →

CHEMILL PHARMA LIMITED

Hong Kong, China

Wacker Chemie Ag

Norway

BERLIN-CHEMIE AG

Bulgaria

News

View all 65 →

NEC and Chugai Pharmaceutical Develop AI System to Accelerate Cancer Drug Combination Discovery

Anthropic Acquires AI Biotech Startup Coefficient Bio for $400 Million to Advance Drug Discovery

Anthropic Launches Claude for Healthcare with Medical Record Integration, Challenging OpenAI in Healthcare AI Market

Page 1 of 71